In a filing, Agios Pharmaceuticals Inc revealed its Chief Commercial Officer Milanova Tsveta unloaded Company’s shares for reported $90233.0 on Jan 06 ’25. In the deal valued at $32.18 per share,2,804 shares were sold. As a result of this transaction, Milanova Tsveta now holds 18,906 shares worth roughly $0.63 million.
Then, Milanova Tsveta bought 2,804 shares, generating $89,279 in total proceeds.
Before that, Scadden David sold 200 shares. Agios Pharmaceuticals Inc shares valued at $9,256 were divested by the Director at a price of $46.28 per share. As a result of the transaction, Scadden David now holds 15,483 shares, worth roughly $0.51 million.
Scotiabank initiated its Agios Pharmaceuticals Inc [AGIO] rating to a Sector outperform in a research note published recently. Leerink Partners also remained covering AGIO and has decreased its forecast on September 27, 2024 with a “Market perform” recommendation from previously “an Outperform” rating. Cantor Fitzgerald started covering the stock on February 08, 2024. It rated AGIO as “an Overweight”.
Price Performance Review of AGIO
On Tuesday, Agios Pharmaceuticals Inc [NASDAQ:AGIO] saw its stock jump 2.50% to $33.23. Over the last five days, the stock has lost -3.12%. Agios Pharmaceuticals Inc shares have risen nearly 1.13% since the year began. Nevertheless, the stocks have risen 55.86% over the past one year. While a 52-week high of $62.58 was reached on 01/08/25, a 52-week low of $20.96 was recorded on 01/17/25. SMA at 50 days reached $45.46, while 200 days put it at $42.51.
Levels Of Support And Resistance For AGIO Stock
The 24-hour chart illustrates a support level at 32.59, which if violated will result in even more drops to 31.94. On the upside, there is a resistance level at 33.69. A further resistance level may holdings at 34.14. The Relative Strength Index (RSI) on the 14-day chart is 36.88, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.89, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 60.04%. Stochastics %K at 28.26% indicates the stock is a holding.
How much short interest is there in Agios Pharmaceuticals Inc?
A steep rise in short interest was recorded in Agios Pharmaceuticals Inc stocks on 2024-12-31, growing by 0.95 million shares to a total of 5.53 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 4.57 million shares. There was a rise of 17.23%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 03, 2023 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $41 price target.
